Overview

Estradiol-Receptor Blockade in Older Men and Women

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
Repletion of testosterone (Te) in older men drives GH secretion after its aromatization to estradiol (E2), which acts via the estrogen receptor (ER). Conversely, we postulate that estrogen deprivation in postmenopausal women attenuates growth hormone (GH) secretion and insulin-like growth factor-1 (IGF-I) production, thus favoring development of metabolic syndrome in men treated with toremifene, a new estrogen antagonist used adjunctively in prostatic cancer
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Estradiol
Toremifene